Clinical Trial Update: The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the acute effects of the ACE inhibitor enalaprilat on flow distribution were completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congestive Cardiomyopathy
• Hypertension

Drugs mentioned

• Enalaprilat (enalaprilat)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Hypertension, Congestive Cardiomyopathy | Phase 3 | Status: COMPLETED | Results posted: 2015-12-18